NCT06962241

Brief Summary

Cesarean section is a common method of delivery worldwide today. According to WHO, cesarean section accounts for more than 1 in 5 (21%) of all births, and it is predicted that approximately one-third (29%) of births will be by cesarean section by 2030. Although cesarean section is a vital and life-saving surgery, it can unnecessarily put mothers and babies at risk for short- and long-term health problems when performed without a medical necessity. Unintended perioperative hypothermia, defined as the inadvertent lowering of core temperature below 36°C during surgery, is a well-known complication of anesthesia. Hypothermia can increase the risk of infection by suppressing the immune system, prolonging the recovery process, and triggering postpartum complications. Maintaining maternal body temperature during cesarean section helps reduce postoperative complications, reduce the risk of infection, and accelerate the recovery process. It is also critical for the health of the baby. Keeping the newborn's body temperature stable can help minimize risks such as hypoxia at birth. However, there are increasing studies showing that temperature control is not only limited to maternal health but also has serious effects on the baby after birth. Therefore, it is understood that maintaining body temperature during cesarean section is an important factor in improving the quality of life for both individuals. This article aims to deeply examine the role of temperature control during cesarean section on maternal and fetal health and the benefits of this intervention.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at below P25 for not_applicable pregnancy

Timeline
1mo left

Started Jun 2025

Shorter than P25 for not_applicable pregnancy

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Jun 2025Jul 2026

First Submitted

Initial submission to the registry

April 29, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 8, 2025

Completed
24 days until next milestone

Study Start

First participant enrolled

June 1, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Expected
Last Updated

May 8, 2025

Status Verified

April 1, 2025

Enrollment Period

9 months

First QC Date

April 29, 2025

Last Update Submit

April 29, 2025

Conditions

Keywords

PREGNANCYNORMOTERMIAAPGAR SCORE

Outcome Measures

Primary Outcomes (1)

  • Concerns of pregnant women who are warmed by a heating pad

    Anxiety of pregnant women warmed with a heating pad will be measured with the Trait Anxiety Inventory (STAI). It is indicated by selecting one of the following options: "(1) None, (2) A Little, (3) A Lot and (4) Completely".

    Questions will be asked half an hour before the caesarean section

Secondary Outcomes (1)

  • Thermal Comfort of Pregnant Women Warmed with a Heating Pad

    will be measured half an hour after the cesarean section

Other Outcomes (3)

  • The effect of warming pregnant women with a heating pad on the Apgar scores of their babies

    The Apgar score of the baby born after cesarean section will be evaluated at the 1st and 5th minutes.

  • Effect of heating pad on shivering of pregnant women

    will be measured half an hour before and half an hour after the caesarean section

  • warming affects serum cortisol level of newborns

    After birth, blood will be taken from the umbilical cord and serum cortisol levels will be checked.

Study Arms (2)

Warming group

EXPERIMENTAL

When the pregnant women in the experimental group were laid on the operating table, they were heated from the back with a heating pad. The heating pad remained on the pregnant woman's back throughout the cesarean section. The cesarean section took an average of 35 minutes from the first surgical incision to the completion of the incision after spinal/epidural anesthesia.

Other: Warming group

Control Group

NO INTERVENTION

The patients in this group are given routine care practices of the clinic.

Interventions

When the pregnant women in the experimental group were laid on the operating table, they were heated from the back with a heating pad. The heating pad remained on the pregnant woman's back throughout the cesarean section. The cesarean section took an average of 35 minutes from the first surgical incision to the completion of the incision after spinal/epidural anesthesia.

Warming group

Eligibility Criteria

Age19 Years - 39 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPregnant women are eligible to work
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Being at least a primary school graduate
  • Having an elective cesarean section with spinal/epidural anesthesia
  • Being at or above the 38th week of pregnancy
  • Being in the ASA I (Normal, healthy person with no disease or systemic problem other than surgical pathology that does not cause a systemic disorder) class
  • Not being diagnosed with high-risk pregnancy (such as oligodydroamnios, premature membrane rupture, gestational diabetes mellitus, preeclampsia, fetal tachycardia, nonreactive NST, intrauterine growth retardation)
  • Having a body mass index of \>19 kg/m2 and \<40 kg/m2
  • Having a singleton pregnancy
  • Having a healthy fetus
  • Having a fasting period of 2-6 hours before surgery
  • Being normothermic (36-37.5°C) (tympanic measurement) before surgery

You may not qualify if:

  • Need for intensive care in the mother or newborn after cesarean section
  • Being anemic with a hemoglobin value below 10 g/dl according to the World Health Organization (2001)
  • Not having platelet values within the reference values
  • Having any disease that will disrupt the bleeding clotting mechanism (hemophilia, liver failure, vitamin K deficiency, etc.)
  • Having a body core temperature above 37.5°C and below 36°C on the morning of surgery
  • Having malnutrition, thyroid function and other endocrine disorders, Parkinson's, peripheral circulatory disorders, Diabetes Mellitus, heart disease and a history of stroke
  • Having any deterioration on the skin surface of the arms and legs (ecchymosis, edema, urticaria, etc.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Munday J, Osborne S, Yates P, Sturgess D, Jones L, Gosden E. Preoperative Warming Versus no Preoperative Warming for Maintenance of Normothermia in Women Receiving Intrathecal Morphine for Cesarean Delivery: A Single-Blinded, Randomized Controlled Trial. Anesth Analg. 2018 Jan;126(1):183-189. doi: 10.1213/ANE.0000000000002026.

    PMID: 28514320BACKGROUND

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer Dr

Study Record Dates

First Submitted

April 29, 2025

First Posted

May 8, 2025

Study Start

June 1, 2025

Primary Completion

March 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

May 8, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share